Stephanie Mehlis

Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

Alice B. Gottlieb, C. Leonardi, Francisco A. Kerdel et al. · British Journal of Dermatology · 2011 · 127 citations

Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the <scp>CLEAR</scp> study

Andrew Blauvelt, Kristian Reich, Stephanie Mehlis et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 23 citations · Full text

Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the <scp>ALLEGRO</scp>‐<scp>LT</scp> phase 3, open‐label study

Christos Tziotzios, Rodney Sinclair, Aleksandra Lesiak et al. · Journal of the European Academy of Dermatology and Venereology · 2025 · 14 citations · Full text